Live from the NIH registry
Studies recruiting near Killeen right now
Top 25 of 102 recruiting studies, sorted by proximity — each links to its official registry page
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,490 participants sought
Research Site — Temple, Texas (22.9 mi)
· Sponsor: AstraZeneca
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
MD Anderson Cancer center — Woodland, Texas (14.7 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Cancer, Immunotherapy
N/A
Observational 2,000 participants sought
Baylor Scott and White Biorepository — Temple, Texas (22.9 mi)
· Sponsor: Elephas
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
IC-MPGN
Phase 3
Interventional 106 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Chronic Kidney Disease(CKD), Type 2 DM
N/A
Interventional 750 participants sought
Baylor Scott & White — Temple, Texas (22.9 mi)
· Sponsor: Duke University
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
GMG Clinical Research, LLC dba Radiance Clinical Research — Lampasas, Texas (26.8 mi)
· Sponsor: Kallyope Inc.
COLON-MD: Colon Cancer Longitudinal Study
Colon Cancer
N/A
Observational 11 participants sought
Baylor Research Institute — Temple, Texas (22.9 mi)
· Sponsor: Baylor Research Institute
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: National Cancer Institute (NCI)
Progressive Achilles Loading Via Clinician E-support
Achilles Tendon Pain, Achilles Tendinopathy
N/A
Interventional 160 participants sought
Carl R. Darnall Army Medical Center (CRDAMC) — Fort Cavazos, Texas (4.9 mi)
· Sponsor: Ruth Chimenti
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Cancer Harboring BRAF Alterations, HGG
Phase 2
Interventional 254 participants sought
Baylor Scott & White Medical Center — Temple, Texas (22.9 mi)
· Sponsor: Fore Biotherapeutics
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
High Grade Epithelial Ovarian Cancer, High Grade Serous Ovarian Cancer
Phase 1, Phase 2
Interventional 884 participants sought
USOR Texas Oncology Gulf Coast — Woodland, Texas (14.7 mi)
· Sponsor: Genmab
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
Baylor Scott & White Medical Center - Temple — Temple, Texas (22.9 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Trauma BPE Prolonged Exposure Therapy for Injured Individuals Admitted to a Level I Trauma Center
Traumatic Injury, PTSD
N/A
Interventional 300 participants sought
Baylor Scott & White Medical Center - Temple — Temple, Texas (22.9 mi)
· Sponsor: Baylor Research Institute
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Stage III Colon Cancer
Phase 2, Phase 3
Interventional 1,912 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: NRG Oncology
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Baylor Scott & White Health — Temple, Texas (22.9 mi)
· Sponsor: Novo Nordisk A/S
Behavioral Insomnia Treatment in Mild Traumatic Brain Injury
Insomnia, Mild Traumatic Brain Injury
N/A
Interventional 160 participants sought
Carl R. Darnall Army Medical Center — Fort Cavazos, Texas (4.9 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Obstructive Hypertrophic Cardiomyopathy
N/A
Observational 1,700 participants sought
Baylor Scott & White Medical Centre - Temple — Temple, Texas (22.9 mi)
· Sponsor: Bristol-Myers Squibb
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
Chronic Myelogenous Leukemia - Chronic Phase
N/A
Observational 1,000 participants sought
Baylor Scott and White Research — Temple, Texas (22.9 mi)
· Sponsor: Novartis Pharmaceuticals
Long-Term Real-World Outcomes Study on Patients Implanted With a Neurostimulator
Chronic Pain
N/A
Observational 2,000 participants sought
Central Texas Pain Institute — Killeen, Texas (2.9 mi)
· Sponsor: Abbott Medical Devices
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Metastatic Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma
Phase 3
Interventional 351 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: BeOne Medicines
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Acute Myeloid Leukemia
Phase 3
Interventional 1,186 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Children's Oncology Group
rTMS-augmented Written Exposure Therapy for PTSD
Post Traumatic Stress Disorder
N/A
Interventional 98 participants sought
Central Texas Veterans Health Care System, Temple, TX — Temple, Texas (22.9 mi)
· Sponsor: VA Office of Research and Development
Enhancing Resiliency and Optimizing Readiness in Military Personnel
Resilience, Psychological, Stress, Physiological
N/A
Interventional 600 participants sought
Fort Hood — Killeen, Texas (2.9 mi)
· Sponsor: The University of Texas Health Science Center at San Antonio
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC)
Phase 3
Interventional 1,040 participants sought
Scott and White Memorial Hospital — Temple, Texas (22.9 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Cancer, Metastatic, Cancer
N/A
Observational 50,000 participants sought
Massive Bio SYNERGY-AI site — Temple, Texas (22.9 mi)
· Sponsor: Massive Bio, Inc.